WS
ARNA

Wedbush Securities’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Wedbush Securities’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,239
Closed -$18K – 897
2016
Q4 		$18K Sell
1,239
-320
-21% -$4.96K ﹤0.01% 807
2016
Q3 		$27K Buy
1,559
+100
+7% +$1.66K ﹤0.01% 810
2016
Q2 		$25K Buy
1,459
+250
+21% +$4.47K ﹤0.01% 759
2016
Q1 		$24K Hold
1,209
– – ﹤0.01% 723
2015
Q4 		$23K Buy
+1,209
New +$24.7K ﹤0.01% 712

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Wedbush Securities's ARNA Position: Q1 2017 in Review

Wedbush Securities sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2017, closing a stake of 1,239 shares — an estimated $18K sold.

Wedbush Securities first reported a position in ARNA in Q4 2015 and held it in 5 quarters. The position peaked at $27K in Q3 2016. 126 funds tracked by Wall St. Rank hold ARNA as of Q1 2017.

  • Wedbush Securities reported no remaining Arena Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Wedbush Securities sold 1,239 Arena Pharmaceuticals Inc shares in Q1 2017, an estimated $18K.
  • Wedbush Securities first reported a position in Arena Pharmaceuticals Inc in Q4 2015 and held it in 5 quarters.
  • Wedbush Securities's Arena Pharmaceuticals Inc position peaked at $27K in Q3 2016.
  • 126 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2017.

Based on Wedbush Securities's 13F filing for Q1 2017, filed 5 May 2017.